Organisms | Evidence |
---|---|
Human immunodeficiency virus | |
Homo sapiens (human) | |
Mesocestoides corti | |
Protophormia terraenovae (northern blowfly) | |
Nippostrongylus brasiliensis |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP |
|
[alpha]-pNP |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC4 | CMP-Neu5Ac |
|
benzyl |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[Ala-Thr(*)-Ala]2-7 |
|
[Ala-Thr(*)-Ala]2-7 |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
---|---|---|---|---|
ST6GALNAC3 | CMP-Neu5Ac |
|
Ser/Thr | |
ST6GAL2 | CMP-Neu5Ac |
|
para-nitrophenol | |
ST6GALNAC2 | CMP-Neu5Ac |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[alpha]-Bz | |
ST6GALNAC2 | CMP-Neu5Ac |
|
Ser/Thr |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
Q99102 | Mucin-4 | ||
Q99674 | Cell growth regulator with EF hand domain protein 1 | ||
Q99715 | Collagen alpha-1(XII) chain | ||
Q99795 | Cell surface A33 antigen | ||
Q99808 | Equilibrative nucleoside transporter 1 | ||
Q99941 | Cyclic AMP-dependent transcription factor ATF-6 beta | ||
Q99969 | Retinoic acid receptor responder protein 2 | ||
Q99988 | Growth/differentiation factor 15 | ||
Q9BQ16 | Testican-3 | ||
Q9BQ69 | ADP-ribose glycohydrolase MACROD1 |
Pathway Name | Organism |
---|---|
E.coli O101 | Escherichia coli |
E.coli O103 | Escherichia coli |
E.coli O107 | Escherichia coli |
E.coli O112ab | Escherichia coli |
E.coli O112ac | Escherichia coli |
E.coli O116 | Escherichia coli |
E.coli O117 | Escherichia coli |
E.coli O125ab | Escherichia coli |
E.coli O127 | Escherichia coli |
E.coli O128ab-H27 | Escherichia coli |
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
35132862 | Simultaneously Identifying and Distinguishing Glycoproteins with O-GlcNAc and O-GalNAc (the Tn Antigen) in Human Cancer Cells | Xu S | 2022 Feb 08 |
|
35130274 | Cooperativity of catalytic and lectin-like domain of Trypanosoma congolense trans-sialidase modulates its catalytic activity | Waespy M | 2022 Feb 07 |
|
36561077 | Targeted protein degradation using the lysosomal pathway | Ghosh S | 2022 Dec 14 |
|
35961667 | Monosaccharide profiling of glycoproteins by capillary electrophoresis with contactless conductivity detection | Tomnikova A | 2022 Aug 27 |
|
36000290 | A novel splicing variant in GALNS in mucopolysaccharidosis IVA and the necessity of re‐evaluating primer sequences | Kim S | 2022 Aug 24 |
|
35997897 | Therapeutic siRNA: State-of-the-Art and Future Perspectives | Friedrich M | 2022 Aug 23 |
|
35962937 | Identification of ADP/ATP Translocase 1 as a Novel Glycoprotein and Its Association with Parkinson’s Disease | Zhang W | 2022 Aug 13 |
|
35913650 | Studies on the partial characterization of extracted glycosaminoglycans from fish waste and its potentiality in modulating obesity through in-vitro and in-vivo | V G | 2022 Aug 01 |
|
35477154 | ABO genotype alters the gut microbiota by regulating GalNAc levels in pigs | Yang H | 2022 Apr 27 |
|
35446989 | Givosiran Likely Inhibits Cytochrome P450 More Substantially Than Reported | Bins S | 2022 Apr 21 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025